Dr. Baker has served on the Board of Directors for Seagen since July 2003, as our lead independent director since February 2005, and was appointed Chair of the Board in May 2022. He is also the founder of Baker Bros. Advisors LP, an advisory firm focused on investments in life science and biotechnology companies. As a board member and investor in many successful biotechnology companies, Dr. Baker’s experience and vision in investment and company building adds significant value to Seagen’s strategy.
Dr. Baker holds a B.S. and a Ph.D. in Immunology from Stanford University, where he also completed two years of medical school. He serves as a member of the board of directors of Kiniksa Pharmaceuticals, Ltd., Kodiak Sciences Inc. and IGM Biosciences, Inc.
Personal Details
Title: Dr
Surname: Baker
DoB: 01/01/1972
Age: 54 years
M/F: Male
Nationality: American
Country of Birth: United States of America
Language: English
Qualification: B.S. PhD Immunology
Industry:
Qualifications & Experience
Industry Experience +5yrs:
Industry Qualification +5yrs?:
Finance experience +5yrs?:
Finance Qualification +5yrs:
Legal experience +5yrs?:
Delinquent director?:
Other Experiences?:
Collapsed company director?:
Other directorships (state)
(only entities turnover at least $5m p/a)
Company
Committee
Position
Date Appointed
Board
Member
01/01/2000
Working history
Committee/s
Company
Committee
Role
Appointment Date
Resignation Date
Seattle Genetics
Board
Member
01/05/2022
Seattle Genetics
Nominations & Governance
Member
01/05/2022
Seattle Genetics
Other (specify)
Member
01/05/2022
Independence Questions
Any family members working for the company?:
Are you doing business with the company?:
Do you hold shares in the company for more than 0.10%? (directly or by representation):
Is your Director annual fee more than 5% of your total income from all sources?:
Are you more than 10 years as a director?:
Are you an executive chairperson?:
InsidEntity has assumed that responses to the Independent Questions are NO as the company has not populated the information. The result will present the Director as Independent.